greeksoup/ stock research

UnitedHealth Group (UNH) FY2009 results: revenue $87.1 billion, up 7.3% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $87.1 billion for fiscal 2009, the year ended 31 December 2009, up 7.3% on the year before. Net income was $3.8 billion, up 28.4%, and diluted earnings per share $3.24. The figures are the company's own, from the 10-K it filed with the SEC on 10 February 2010.

Revenue
$87.1 billion
+7.3% on the year
FY2007FY2009
Operating margin
7.3%
6.5% a year earlier
FY2007FY2009
Net income
$3.8 billion
+28.4% on the year
FY2007FY2009
Diluted EPS
$3.24
+35.0% on the year
FY2007FY2009

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2009FY2008FY2007On the yearLast 8 years
Revenue87,13881,18675,431+7.3%
Cost of revenue1,7651,480768+19.3%
Gross profit85,37379,70674,663+7.1%
Gross margin98.0%98.2%99.0%
Selling, general and administrative12,73413,10310,583-2.8%
Operating income6,3595,2637,849+20.8%
Operating margin7.3%6.5%10.4%
Interest expense551639544-13.8%
Pre-tax income5,8084,6247,305+25.6%
Income tax1,9861,6472,651+20.6%
Effective tax rate34.2%35.6%36.3%
Net income3,8222,9774,654+28.4%
Net margin4.4%3.7%6.2%
Diluted EPS$3.24$2.40$3.42+35.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2009FY2008FY2007On the yearLast 8 years
Operating cash flow5,6254,2385,877+32.7%
Capital expenditure739791871-6.6%
Free cash flow4,8863,4475,006+41.7%
Free cash flow margin5.6%4.2%6.6%
Cash from investing-976-5,072-4,147
Cash from financing-2,275-605-3,185
Depreciation and amortisation991981796+1.0%
Share-based compensation334305505+9.5%
Buybacks1,8012,6846,599-32.9%
Dividends paid36.037.040.0-2.7%
Dividend per share$0.03$0.03$0.030.0%
Diluted shares, weighted1,179m1,241m1,361m-5.0%
Shares outstanding at period end1,147m1,201mn/a-4.5%

Balance sheet

$ millionFY2009FY2008FY2007On the yearLast 8 years
Shareholders' equity23,60620,78020,063+13.6%
Debt11,17312,794n/a-12.7%
Other liabilities24,26622,241n/a+9.1%
Total liabilities and equity59,04555,815n/a+5.8%
Fixed assets9462,181n/a-56.6%
Goodwill20,72720,088n/a+3.2%
Intangible assets2,3812,329n/a+2.2%
Investments14,55014,149n/a+2.8%
Cash and equivalents9,8007,4268,865+32.0%
Receivables1,9541,929n/a+1.3%
Other assets8,6877,713n/a+12.6%
Total assets59,04555,815n/a+5.8%

10-K for the year ended 31 December 2009, filed 10 February 2010: the filing.